Although chemical modification studies are needed to clarify the pharmacological mechanisms of SPE’s components, particularly cosmosiin, the present study confirmed that cosmosiin has potent immunotherapeutic properties against cancer via inhibiting PD-1/PD-L1 pathway. Here, PDCD1 is linked to cancer.